Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pathmanathan Rajadurai

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Case Reports in Hematology|September 12, 2022
A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and DexamethasoneJew Win Kuan, Sing Ling Chai, Pathmanathan Rajadurai, et al.
Toxins|October 21, 2016
Proteomic Characterization and Comparison of Malaysian Tropidolaemus wagleri and Cryptelytrops purpureomaculatus Venom Using Shotgun-ProteomicsSyafiq Asnawi Zainal Abidin, Pathmanathan Rajadurai, Md Ezharul Hoque Chowdhury, et al.
Breast Cancer Research : BCR|April 26, 2023
TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effectsMohana Eswari Ragu, Joanna Mei Ch'wan Lim, Pei-Sze Ng, et al.
Frontiers in Oncology|December 19, 2025
Unraveling the complexity of PD-L1 assays: a descriptive review of the methodology, scoring, and practical implicationsGilad W Vainer, Sunil S Badve, Pathmanathan Rajadurai, et al.
Journal of Breast Cancer|December 2, 2024
Prevalence of Programmed Death-Ligand 1 Positivity Using SP142 in Patients With Advanced Stage Triple-Negative Breast Cancer in Malaysia: A Cross-Sectional StudyPathmanathan Rajadurai, Ning Yi Yap, Seow Fan Chiew, et al.
Cancers|July 13, 2024
Consensus Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2)-Low Testing in Breast Cancer in MalaysiaPathmanathan Rajadurai, Sarala Ravindran, Bang Rom Lee, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 18, 2014
Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient populationChong-Kin Liam, Hwong-Ruey Leow, Soon-Hin How, et al.
Infectious Agents and Cancer|June 27, 2018
Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infectionLee Fah Yap, Sook Ling Lai, Anthony Rhodes, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2019
Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological SocietyPathmanathan Rajadurai, Phaik Leng Cheah, Soon Hin How, et al.
Indian Journal of Pathology & Microbiology|October 21, 2021
HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring studySuria Hayati Md Pauzi, Noraidah Masir, Azyani Yahaya, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Case Reports in Hematology|September 12, 2022
A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and DexamethasoneJew Win Kuan, Sing Ling Chai, Pathmanathan Rajadurai, et al.
Toxins|October 21, 2016
Proteomic Characterization and Comparison of Malaysian Tropidolaemus wagleri and Cryptelytrops purpureomaculatus Venom Using Shotgun-ProteomicsSyafiq Asnawi Zainal Abidin, Pathmanathan Rajadurai, Md Ezharul Hoque Chowdhury, et al.
Breast Cancer Research : BCR|April 26, 2023
TP53 somatic mutations in Asian breast cancer are associated with subtype-specific effectsMohana Eswari Ragu, Joanna Mei Ch'wan Lim, Pei-Sze Ng, et al.
Frontiers in Oncology|December 19, 2025
Unraveling the complexity of PD-L1 assays: a descriptive review of the methodology, scoring, and practical implicationsGilad W Vainer, Sunil S Badve, Pathmanathan Rajadurai, et al.
Journal of Breast Cancer|December 2, 2024
Prevalence of Programmed Death-Ligand 1 Positivity Using SP142 in Patients With Advanced Stage Triple-Negative Breast Cancer in Malaysia: A Cross-Sectional StudyPathmanathan Rajadurai, Ning Yi Yap, Seow Fan Chiew, et al.
Cancers|July 13, 2024
Consensus Guidelines on Human Epidermal Growth Factor Receptor 2 (HER2)-Low Testing in Breast Cancer in MalaysiaPathmanathan Rajadurai, Sarala Ravindran, Bang Rom Lee, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 18, 2014
Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient populationChong-Kin Liam, Hwong-Ruey Leow, Soon-Hin How, et al.
Infectious Agents and Cancer|June 27, 2018
Clinico-pathological features of oropharyngeal squamous cell carcinomas in Malaysia with reference to HPV infectionLee Fah Yap, Sook Ling Lai, Anthony Rhodes, et al.
Lung Cancer (Amsterdam, Netherlands)|August 26, 2019
Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological SocietyPathmanathan Rajadurai, Phaik Leng Cheah, Soon Hin How, et al.
Indian Journal of Pathology & Microbiology|October 21, 2021
HER2 testing by immunohistochemistry in breast cancer: A multicenter proficiency ring studySuria Hayati Md Pauzi, Noraidah Masir, Azyani Yahaya, et al.
Pageof 4